Immunization against leukemia inhibitory factor and its receptor suppresses tumor formation of breast cancer initiating cells in BALB/c mouse

Abstract Immunotherapy is a promising approach for specific targeting of cancer cells. Leukemia inhibitory factor (LIF) regulates several features of cancers and cancer stem cells (CSCs) through binding to LIF receptor (LIFR). In this study, we investigated the consensus of LIF and LIFR immunization...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Zahra Ghanei, Nahid Mehri, Abbas Jamshidizad, Morteza Daliri Joupari, Mehdi Shamsara
Format: article
Langue:EN
Publié: Nature Portfolio 2020
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/758b9fb6182845adaa8c87589de7b179
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!